Drugs Against Avian Influenza A Virus: Design of Novel Sulfonate Inhibitors of Neuraminidase N1

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|21|3478-3487

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.21, 2014-05, pp. : 3478-3487

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Computational Model for Docking of Noncompetitive Neuraminidase Inhibitors and Probing their Binding Interactions with Neuraminidase of Influenza Virus H5N1

By  

Current Computer - Aided Drug Design, Vol. 12, Iss. 4, 2016-12 ,pp. : 272-281

Bentham Science Publishers

Access to resources Recommend Favorite

QSAR Study of H1N1 Neuraminidase Inhibitors from Influenza a Virus

By  

Letters in Drug Design & Discovery, Vol. 11, Iss. 4, 2014-05 ,pp. : 420-427

Bentham Science Publishers

Access to resources Recommend Favorite

Binding Mechanism of H5N1 Influenza Virus Neuraminidase with Ligands and its Implication for Drug Design

By  

Medicinal Chemistry, Vol. 5, Iss. 3, 2009-05 ,pp. : 242-249

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in the Structure-Based Design of the Influenza A Neuraminidase Inhibitors

By  

Current Drug Targets, Vol. 11, Iss. 3, 2010-03 ,pp. : 315-326

Bentham Science Publishers

Access to resources Recommend Favorite

Oseltamivir/zanamivir: Development of neuraminidase inhibitor resistance in influenza A virus H1N1 subtype in a child: case report

By  

Reactions Weekly, Vol. 1, Iss. 1326, 2010-01 ,pp. : 26-27

Adis International

Access to resources Recommend Favorite